UNSPSC 51384632: Phenylbutazone calcium

This classification denotes a nonsteroidal antiinflammatory drug 2C19H19N2O2.Ca, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RD7H6MM2DL, chemically known as calcium 4-butyl-1,2-diphenyl-3,5-pyrazolidinedione, but more generally known as phenylbutazone calcium, which bears US NIH Compound Identifier 112362. European Medicines Agency schedules Phenylbutazone calcium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03772MIG.

Most nations, for tariff and trade purposes, schedule phenylbutazone calcium under HS 29331910 and SITC 51571. As of Q4 2014, PHENYLBUTAZONE CALCIUM remains US FDA's Preferred Term for this commodity. SMILES: CCCC[C-]1C(=O)N(N(C1=O)C2CCCCC2)C3CCCCC3.CCCC[C-]1C(=O)N(N(C1=O)C2CCCCC2)C3CCCCC3.[CA+2].

UNSPSC 51384632 Phenylbutazone calcium is a Commodity code that shows minimal alignment with recent state and local procurement activity. The single recent opportunity tagged under this code—Seminole County, Florida's IFB60459723LAS for Naloxone and drug deactivation systems posted on June 30, 2026—involves pharmaceutical products and public health supplies that fall outside the scope of phenylbutazone calcium, an equine anti-inflammatory medication. The mismatch suggests either a miscoding of the opportunity or limited recent activity under this specific commodity code.

Seminole County, Florida posted the only identifiable recent solicitation under this code, an IFB for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The response deadline was July 26, 2023 (note: the posting date of June 30, 2026 appears to be a data error given the 2023 response date). The county required electronic bid submission through its e-Procurement Portal, E-Verify compliance, and standard insurance coverage. No explicit set-aside designations were specified. The procurement history does not support meaningful characterization of issuing-body mix or geographic concentration under this code.